BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 37488743)

  • 1. Anthropometrics of neonates born to mothers with PCOS with metformin or placebo exposure in utero.
    Nilsen GØ; Simpson MR; Hanem LGE; Løvvik TS; Ødegård R; Stokkeland LMT; Andersen MS; Juliusson PB; Vanky E
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):176-187. PubMed ID: 37488743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS.
    Hjorth-Hansen A; Salvesen Ø; Engen Hanem LG; Eggebø T; Salvesen KÅ; Vanky E; Ødegård R
    J Clin Endocrinol Metab; 2018 Feb; 103(2):740-747. PubMed ID: 29165598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal thyroid function and offspring birth anthropometrics in women with polycystic ovary syndrome.
    Trouva A; Alvarsson M; Calissendorff J; Åsvold BO; Ujvari D; Hirschberg AL; Vanky E
    Front Endocrinol (Lausanne); 2024; 15():1388473. PubMed ID: 38868742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs.
    Hanem LGE; Stridsklev S; Júlíusson PB; Salvesen Ø; Roelants M; Carlsen SM; Ødegård R; Vanky E
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1612-1621. PubMed ID: 29490031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study.
    Grindheim S; Ebbing C; Karlsen HO; Skulstad SM; Real FG; Lønnebotn M; Løvvik T; Vanky E; Kessler J
    PLoS One; 2022; 17(1):e0262987. PubMed ID: 35089960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.
    Carlsen SM; Vanky E
    Hum Reprod; 2010 Mar; 25(3):786-90. PubMed ID: 20023292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal PCOS status and metformin in pregnancy: Steroid hormones in 5-10 years old children from the PregMet randomized controlled study.
    Hanem LGE; Salvesen Ø; Madsen A; Sagen JV; Mellgren G; Juliusson PB; Carlsen SM; Vanky E; Ødegård R
    PLoS One; 2021; 16(9):e0257186. PubMed ID: 34499672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus.
    Andræ F; Abbott D; Stridsklev S; Schmedes AV; Odsæter IH; Vanky E; Salvesen Ø
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3762-70. PubMed ID: 32866967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
    Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
    Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthropometric Measurements in Newborns: A Comparative Study of Infants Born to Mothers With and Without Polycystic Ovary Syndrome.
    S J; S N; S SK; Haripriya G; Sheriff D; S JC; Mohammad H; K P
    Cureus; 2023 Oct; 15(10):e48012. PubMed ID: 38034170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.
    Dodd JM; Grivell RM; Deussen AR; Hague WM
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010564. PubMed ID: 30039871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT.
    Greger HK; Hanem LGE; Østgård HF; Vanky E
    BMC Pediatr; 2020 Feb; 20(1):60. PubMed ID: 32039724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns.
    Vanky E; Carlsen SM
    Fertil Steril; 2012 Feb; 97(2):509-15. PubMed ID: 22154766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.
    Anderson H; Fogel N; Grebe SK; Singh RJ; Taylor RL; Dunaif A
    J Clin Endocrinol Metab; 2010 May; 95(5):2180-6. PubMed ID: 20228162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
    Tanvig M
    Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials.
    Ujvari D; Trouva A; Hirschberg AL; Vanky E
    BMJ Open; 2023 Nov; 13(11):e073619. PubMed ID: 37989369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth size after embryo cryopreservation: larger by all measures?
    Landsverk E; Westvik-Johari K; Romundstad LB; Opdahl S
    Hum Reprod; 2023 Jul; 38(7):1379-1389. PubMed ID: 37178338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.
    Fornes R; Simin J; Nguyen MH; Cruz G; Crisosto N; van der Schaaf M; Engstrand L; Brusselaers N
    Reprod Biol Endocrinol; 2022 Feb; 20(1):30. PubMed ID: 35130922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.
    Sharpe A; Morley LC; Tang T; Norman RJ; Balen AH
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013505. PubMed ID: 31845767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.